Please login to the form below

Not currently logged in
Email:
Password:

Manifesto puts patients first

A Healthcare Manifesto aimed at putting patients first has been published today by EuropaBio

A Healthcare Manifesto aimed at putting patients first has been published today by EuropaBio, the European Association for Bioindustries. In announcing its new policy priorities for 2009-2010, it outlines ways of promoting patient-centred healthcare systems.

The key policy areas involve: communicating the value of biotechnology innovation for healthcare systems; promoting Europe as the leading research hub for biotechnology and life sciences in the world; supporting the EU in delivering on its vision for access to orphan medicinal products for all patients affected by rare diseases; promoting reward for innovation, and sensitivity about, and understanding of, bio-ethical issues and values.

Biotechnology enables the development and manufacture of therapies for a number of rare and very rare diseases including genetic diseases, collectively affecting some 20 to 30 million Europeans and their families. Modern biotechnology leads to more targeted research that allows a better understanding of diseases, their causes and the identification of the best responders to new therapies.  

The chairman of EuropaBio's Healthcare Council, Andrea Rappagliosi, said: "EuropaBio's Healthcare Manifesto is our political road map for how to deliver a patient–centred approach to modern healthcare. This means putting patients first in Europe and working together with health authorities, payers and reimbursement agencies in order to ensure timely access to innovative therapies." 

"Our Healthcare Manifesto clarifies EuropaBio's policy goals and gives our Healthcare Council a strong position when working with policy makers," said Willy De Greef, secretary general of EuropaBio.

21st April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics